OMB
.report
Search
Study Phase 1 Informed Consent
Communicating Composite Scores in Direct-to-Consumer (DTC) Prescription Drug Advertising
OMB: 0910-0743
IC ID: 206926
OMB.report
HHS/FDA
OMB 0910-0743
ICR 201305-0910-005
IC 206926
( )
Documents and Forms
Document Name
Document Type
Phase 1 informed consent.doc
Other-Informed Consent
Information Collection (IC) Details
View Information Collection (IC)
IC Title:
Study Phase 1 Informed Consent
Agency IC Tracking Number:
Is this a Common Form?
No
IC Status:
New
Obligation to Respond:
Voluntary
CFR Citation:
Information Collection Instruments:
Document Type
Form No.
Form Name
Instrument File
URL
Available Electronically?
Can Be Submitted Electronically?
Electronic Capability
Other-Informed Consent
Phase 1 informed consent.doc
Yes
Yes
Fillable Fileable Signable
Federal Enterprise Architecture Business Reference Module
Line of Business:
Health
Subfunction:
Immunization Management
Privacy Act System of Records
Title:
FR Citation:
Number of Respondents:
1,800
Number of Respondents for Small Entity:
0
Affected Public:
Individuals or Households
Percentage of Respondents Reporting Electronically:
100 %
Approved
Program Change Due to New Statute
Program Change Due to Agency Discretion
Change Due to Adjustment in Agency Estimate
Change Due to Potential Violation of the PRA
Previously Approved
Annual Number of Responses for this IC
1,800
0
1,800
0
0
0
Annual IC Time Burden (Hours)
54
0
54
0
0
0
Annual IC Cost Burden (Dollars)
0
0
0
0
0
0
Documents for IC
Title
Document
Date Uploaded
No associated records found
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.